A new public health tool for risk assessment of abnormal glucose levels

Preventing Chronic Disease

Volumn 7, Issue 2, 2010, Pages

  He, Guozhong ^a   Sentell, Tetine ^b   Schillinger, Dean ^c,d  

^a University of Hawaii at Manoa ^*  (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MODEL; BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; NUTRITION; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; MODELS, BIOLOGICAL; NUTRITION SURVEYS; RISK FACTORS; YOUNG ADULT;

EID: 77952313429     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. A full accounting of diabetes and prediabetes in the US population, 1988-1994 and 2005-2006. Diabetes Care 2009;32(2):287-94
2. Black S. Diabetes, diversity, and disparity: what do we do with the evidence? Am J Public Health 2002; 92(4): 543-8.
3. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11(17);1-125.
4. Nathan DM, Davidson MB, DeFronzo RA, Henry RR, Pratley R, Zinman B, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-9.
5. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
6. Knowler WC, Barrett-Conner E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
7. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005; 2(1): 9-15.
8. Centers for Disease Control and Prevention. Self-reported prediabetes and risk-reduction activities - United States, 2006. MMWR Morb Motal Wkly Rep 2008;57(44):1203-5.
9. Lara C, Ponce de Leon S, Foncerrada H, Vega M. Diabetes or impaired glucose tolerance: does the label matter? Diabetes Care 2007; 30(12): 3029-30.
10. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003; 26(3): 645-9.
11. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19(9): 708-23.
12. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78: 305-12.
13. Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care 2008; 14(12): 791-8.
14. Heikes KE, Eddy DM, Arondekar B, Schlessinger L. Diabetes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 2008; 31: 1040-5.
15. Schmidt MI, Duncan BB, Vigo A, Pankow J, Ballantyne CM, Couper D, et al. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care 2003; 26(5): 1338-43.
16. Schwarz PEH, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2008; 40: 1-12.
17. Koopman RJ, Mainous AG, Everett CJ, Carter RE. Tool to assess likelihood of fasting glucose impairment (TAG-It). Ann Fam Med 2008; 6(6): 555-61.
18. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26(3): 725-31.
19. Nelson KM, Boyko EJ. Predicting impaired glucose tolerance using common clinical information: data from the third National Health and Nutrition Examination Survey. Diabetes Care 2003; 26(7): 2058-62.
20. Park PJ, Griffin SJ, Sargeant L, Wareham NJ. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 2002; 25(6): 984-8.
21. Analytic and reporting guidelines: the National Health and Nutrition Examination Survey, NHANES 2005-2006. Hyattsville (MD): National Center for Health Statistics, Centers for Disease Control and Prevention; 2006.
22. National Center for Health Statistics. National Health and Nutrition Examination Survey 2005-2006. Two-hour oral glucose tolerance test (OGTT). Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Comtrol and Prevention; 2008.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(S1): S55-60.
24. Akaike H. Factor analysis and AIC. Psychometrika 1987; 52: 317-32.
25. SAS Institute. SAS/STAT 9.1 user's guide. SAS Publishing; 2004.
26. Glümer C, Vistisen D, Borch-Johnsen K, Colagiuri S. DETECT-2 Collaboration. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006; 29(2): 410-4.